Author:
Nagano H.,Mizutani K.,Sawa K.,Ozaki Y.,Murakami A.
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference11 articles.
1. Jenison EL, Montag AG, Griffiths CT, et al. (1989) Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma. Gynecol Oncol 32:65–71
2. Omura GA, Brady MF, Homesley HD, et al. (1991) Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience. J Clin Oncol 9:1138–1150
3. Goff BA, Sainz de la Cuesta R, Muntz HG, et al. (1996) Clear cell carcinoma of the ovary. A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 60:412–417
4. Durand RE, Goldie JH (1987) Interaction of etoposide and cisplatin in an in vitro tumor model. Cancer Treat Rep 71:673–679
5. Kodama J, Tokumo K, Ikuhashi H, et al. (1997) Evaluation of etoposide and cisplatin (carboplatin) in refractory or recurrent epithelial ovaran cancer. J Jpn Soc Cancer Ther 32:186–192